All In Biotech

Drug Trial Radar · NCT06085183

Indigotindisulfonate Sodium as an Aid in Determination of Ureteral Patency in Patient's With Renal Impairment

An Open-Label, Randomized, Parallel Group Study to Investigate the Influence of Renal Impairment on the Efficacy and Safety of Two Doses of Bludigo™ When Used as an Aid in the Determination of Ureteral Patency

Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

48

Planned (sponsor's estimate)

Start

Dec 20, 2023

Primary completion

Dec 30, 2026

Study completion Dec 31, 2026

Sponsor

Lead sponsor
Prove pharmIndustry
Sponsor type
Industry
First posted
Oct 16, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Crossover
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Diagnostic
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an open label, randomized, multicenter study to evaluate the efficacy and safety of two dose levels (2.5 mL and 5.0 mL) of Indigotindisulfonate Sodium Injection, USP 0.8% when used as an aid in the determination of ureteral patency in patients with different degrees of renal impairment.

Conditions

  • Ureter Injury

Interventions

  • Saline Injection 0.9%Other

    Placebo

  • Indigotindisulfonate sodium 0.8%Drug

    Experimental contrast dye that is commonly used as a visualization aid in pelvic and abdominal surgeries and for various diagnostic procedures in medical practice.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Paired sample difference (Bludigo - Saline) in urine jet conspicuity score.Time frame: 10 to 15 minutes post study drug administration
  2. Responders to BludigoTime frame: 10 to 15 minutes post study drug administration

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Albany Medical Center

    Albany, New York · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.